Osteopore Limited (ASX:OSX)
Australia flag Australia · Delayed Price · Currency is AUD
0.0090
-0.0010 (-10.00%)
Feb 11, 2026, 1:42 PM AEST

Osteopore Income Statement

Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
2.852.762.221.691.111.5
Revenue Growth (YoY)
5.52%24.59%31.02%52.05%-26.02%265.54%
Cost of Revenue
0.620.470.580.420.30.55
Gross Profit
2.232.31.641.270.810.96
Selling, General & Admin
3.233.514.063.864.713.61
Research & Development
1.211.141.571.43--
Other Operating Expenses
0.550.420.290.18-0.29-0.72
Operating Expenses
5.215.246.465.474.422.88
Operating Income
-2.99-2.94-4.82-4.19-3.6-1.93
Interest Expense
-0.39-0.43-0.02-0.01-0.02-0.02
Interest & Investment Income
000.010.01--
Other Non Operating Income (Expenses)
-0.03-----
EBT Excluding Unusual Items
-3.36-3.37-4.83-4.2-3.62-1.95
Pretax Income
-3.36-3.33-4.83-4.2-3.62-1.95
Income Tax Expense
0.010.020.04---
Net Income
-3.36-3.35-4.87-4.2-3.62-1.95
Net Income to Common
-3.36-3.35-4.87-4.2-3.62-1.95
Shares Outstanding (Basic)
1137810887
Shares Outstanding (Diluted)
1137810887
Shares Change (YoY)
82.42%719.13%16.00%5.37%9.90%269.93%
EPS (Basic)
-0.03-0.04-0.51-0.51-0.46-0.27
EPS (Diluted)
-0.03-0.04-0.51-0.51-0.46-0.27
Free Cash Flow
-2.69-3.1-3.73-4.06-4-2.14
Free Cash Flow Per Share
-0.02-0.04-0.39-0.49-0.51-0.30
Gross Margin
78.20%83.08%73.78%75.24%72.92%63.50%
Operating Margin
-105.07%-106.57%-217.41%-247.70%-323.86%-128.16%
Profit Margin
-118.22%-121.34%-219.72%-247.89%-325.32%-129.33%
Free Cash Flow Margin
-94.50%-112.30%-168.19%-239.74%-359.41%-142.15%
EBITDA
-2.51-2.47-4.4-4.02-3.42-1.8
EBITDA Margin
-88.19%-89.23%-198.47%-237.25%--119.40%
D&A For EBITDA
0.480.480.420.180.180.13
EBIT
-2.99-2.94-4.82-4.19-3.6-1.93
EBIT Margin
-105.07%-106.57%-217.41%-247.70%--128.16%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.